The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

Cencora, Inc. COR reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of $3.73, which beat the Zacks Consensus Estimate of $3.50 by 6.6%. The bottom line also improved 13.7% year over ...

Several key developments in the health sector involve major pharmaceutical companies navigating growth challenges and ...

Many Chief Information Security Officers (CISOs) aim to enhance their crisis simulation capabilities in 2025 with the aim to prepare for potential full-scale cyber crises, according to a new study by ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money, has been ...

Cencora, Inc. COR is well-poised for growth ... Zacks Investment Research Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve 10.4% over the next five years.

Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $49.31 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 (Buy) ...